Imagine waking up every morning knowing you’re part of a company with the vision of delivering world-leading diagnostics and improved patient pathways for everyone. That is my reality, and it makes me fly out of bed! After nearly a decade of investment in technology, development and domain expertise, we’re clear on how to make the fastest impact – by establishing our own ultra-modern digital pathology labs worldwide. This approach enables us to progress quickly and deliver greater value to patients, clinicians, and health systems.
Words from our CEO
Fredrik Palm, Chief Executive Officer
Specialisation is key to Inify, as it drives excellence. We focus on selected indications, starting with prostate cancer and gastrointestinal diagnostics. Our scalable system supports expansion into additional high-volume areas, though we don't aim to cover everything. Our sole ambition is to be world-leading in the services we provide.
Inclusion is another priority. Our services are available for clinicians and patients, in both public and private healthcare settings, enabling our ambition to provide equal care for everyone.
“We bring 40 years of experience within image analysis, paired with extensive domain knowledge in pathology and medical informatics.”
Clinical pathology is currently under huge pressure, with heavy workloads and limited, often declining resources. Aging populations, increasing cancer incidence, more frequent exams and screening programmes are driving an increase in workloads. While a shortage of pathology professionals makes scaling through additional staffing unfeasible.
There is a buzz about “going digital”, and the use of AI to solve these current and future challenges. While I fully agree, reality shows that the transformation from analogue to digital workflows in existing clinical pathology laboratories is highly complex, from a technical, legacy, and commercial perspective. Many respectable companies offer innovative, high-performing products within the field; however, no chain is stronger than its weakest link, and in many labs, there are several. Tissue preparation processes, integration between technical innovations, human and machine integration are all essential to an efficient workflow. Until this integration is seamless and complete, digitalisation adds limited value in the routine clinical setting and can lead to negative effects in some cases.
These factors, combined with our long-term investors, are the foundation for Inify Laboratories. We bring 40 years of experience within image analysis, paired with extensive domain knowledge in pathology and medical informatics.
The backbone of our concept is a scalable system where processes, machines and humans are seamlessly integrated in a standardised workflow, ensuring utmost efficiency and quality. Only then, can we deliver real enhanced patient value, and we will never compromise on that goal.
“Reality shows that the transformation from analogue to digital workflows in existing clinical pathology laboratories is highly complex.”
Standardized and structured data allows for seamless, continuous development of powerful machine learning technology and process optimisation. This in turn provides both employed and consultant pathologists with valuable tools and prerequisites, maximising diagnosis efficiency and quality. Inify Laboratories’ concept is scalable through increased volume, indications and geographies.
If I were to pick a single success factor, it would be our cross-functional team, with clinical, laboratory and technical expertise, arranged in the same organisation with a common goal – to improve patient care and healthcare services. It is with great pride we reached the opening of our unique laboratory in Stockholm in June 2023 that has been duplicated with our brand-new laboratory in Oxfordshire UK. Both offering our services to customers across Northern Europe and United Kingdom.
–
Fredrik Palm
Chief Executive Officer